Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

Base editing utilizes enzymes to modify single amino acids at the most foundational unit of DNA, called a base.

The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...

Financial writer discusses MGX's gene editing technology, cash runway, and lack of clinical data for potential future ...

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

The treatment uses gene-editing tool Crispr, which earned its inventors ... common in people with an African or Caribbean family background. Symptoms can include very severe pain, serious and ...

Casgevy, also known as exa-cel, was the first treatment to be licensed using gene-editing tool Crispr (Alamy/PA ... with an African or Caribbean family background. Symptoms can include very ...